Davenport & CO LLC Lantern Pharma Inc. Call Options Transaction History
Davenport & CO LLC
- $16.8 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LTRN
# of Institutions
34Shares Held
1.31MCall Options Held
39.8KPut Options Held
6.1K-
Vanguard Group Inc Valley Forge, PA364KShares$1.13 Million0.0% of portfolio
-
Cm Management, LLC185KShares$577,2000.57% of portfolio
-
New Edge Advisors, LLC New Orleans, LA137KShares$428,4940.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$272,7970.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny84KShares$262,0800.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $33.8M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...